De NovoSirolimus and Reduced-Dose Tacrolimus Versus Standard-Dose Tacrolimus After Liver Transplantation: The 2000-2003 Phase II Prospective Randomized Trial
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
De NovoSirolimus and Reduced-Dose Tacrolimus Versus Standard-Dose Tacrolimus After Liver Transplantation: The 2000-2003 Phase II Prospective Randomized Trial
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF TRANSPLANTATION
Volume 14, Issue 2, Pages 356-366
Publisher
Wiley
Online
2014-01-24
DOI
10.1111/ajt.12543
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tacrolimus Exposure After Liver Transplantation in Randomized Controlled Trials: Too Much for Too Long
- (2013) M. Rodríguez-Perálvarez et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Everolimus With Reduced Tacrolimus in Liver Transplantation
- (2013) P. De Simone et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Calcineurin Inhibitor-Free Mycophenolate Mofetil/Sirolimus Maintenance in Liver Transplantation: The Randomized Spare-the-Nephron Trial
- (2013) Lewis Teperman et al. LIVER TRANSPLANTATION
- Sirolimus Conversion for Renal Dysfunction in Liver Transplant Recipients: The Devil Really Is in the Details…
- (2012) G. J. McKenna et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Sirolimus Conversion Regimen Versus Continued Calcineurin Inhibitors in Liver Allograft Recipients: A Randomized Trial
- (2012) M. F. Abdelmalek et al. AMERICAN JOURNAL OF TRANSPLANTATION
- A Randomized, Controlled Study to Assess the Conversion From Calcineurin-Inhibitors to Everolimus After Liver Transplantation-PROTECT
- (2012) L. Fischer et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Everolimus With Reduced Tacrolimus Improves Renal Function inDe NovoLiver Transplant Recipients: A Randomized Controlled Trial
- (2012) P. De Simone et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Impact of sirolimus and tacrolimus on mortality and graft loss in liver transplant recipients with or without hepatitis C virus: An analysis of the Scientific Registry of Transplant Recipients Database
- (2012) Kymberly D. Watt et al. LIVER TRANSPLANTATION
- Sirolimus and Cardiovascular Disease Risk in Liver Transplantation
- (2012) Greg J. McKenna et al. TRANSPLANTATION
- Biliary Complications after Orthotopic Liver Transplantation: A Review of Incidence and Risk Factors
- (2012) M. Gastaca TRANSPLANTATION PROCEEDINGS
- Limiting Hepatitis C Virus Progression in Liver Transplant Recipients Using Sirolimus-Based Immunosuppression
- (2011) G. J. McKenna et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Reduced-Dose Tacrolimus with Mycophenolate Mofetil vs. Standard-Dose Tacrolimus in Liver Transplantation: A Randomized Study
- (2011) K. Boudjema et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Efficacy and Safety of Early Cyclosporine Conversion to Sirolimus with Continued MMF-Four-Year Results of the Postconcept Study
- (2011) Y. Lebranchu et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Management of hepatocellular carcinoma: An update
- (2011) Jordi Bruix et al. HEPATOLOGY
- Sirolimus – It doesn’t deserve its bad Rap(a)
- (2011) Greg J. McKenna et al. JOURNAL OF HEPATOLOGY
- Early Withdrawal of Calcineurin Inhibitors and Everolimus Monotherapy in de novo Liver Transplant Recipients Preserves Renal Function
- (2010) M. Masetti et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Use of sirolimus in liver transplant recipients with renal insufficiency: A systematic review and meta-analysis
- (2010) Sumeet K. Asrani et al. HEPATOLOGY
- Multicentric outcome analysis of sirolimus-based immunosuppression in 252 liver transplant recipients
- (2009) Michele Molinari et al. TRANSPLANT INTERNATIONAL
- Delayed Introduction of Reduced-Dose Tacrolimus, and Renal Function in Liver Transplantation: The ‘ReSpECT' Study
- (2008) J. M. Neuberger et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Conversion to everolimus monotherapy in maintenance liver transplantation: feasibility, safety, and impact on renal function
- (2008) Paolo De Simone et al. TRANSPLANT INTERNATIONAL
- Effects of Everolimus Monotherapy on Hematological Parameters and Iron Homeostasis in De Novo Liver Transplant Recipients: Preliminary Results
- (2008) M. Masetti et al. TRANSPLANTATION PROCEEDINGS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started